Yipinhong Pharmaceutical Co Ltd
SZSE:300723

Watchlist Manager
Yipinhong Pharmaceutical Co Ltd Logo
Yipinhong Pharmaceutical Co Ltd
SZSE:300723
Watchlist
Price: 33.82 CNY 2.64%
Market Cap: ¥15.3B

Operating Margin

-53.4%
Current
Declining
by 46.4%
vs 3-y average of -7.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-53.4%
=
Operating Income
¥-547.5m
/
Revenue
¥1B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-53.4%
=
Operating Income
¥-547.5m
/
Revenue
¥1B

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Yipinhong Pharmaceutical Co Ltd
SZSE:300723
15.3B CNY
Loading...
US
Eli Lilly and Co
NYSE:LLY
948.8B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
563B USD
Loading...
CH
Roche Holding AG
SIX:ROG
282B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
214.9B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
288.1B USD
Loading...
CH
Novartis AG
SIX:NOVN
225.6B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
146.4B USD
Loading...
FR
Sanofi SA
PAR:SAN
98B EUR
Loading...

Market Distribution

Lower than 92% of companies in China
Percentile
8th
Based on 8 544 companies
8th percentile
-53.4%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Yipinhong Pharmaceutical Co Ltd
Glance View

Market Cap
15.3B CNY
Industry
Pharmaceuticals

Yipinhong Pharmaceutical Co Ltd has carved its niche in the pharmaceutical landscape of China, with its roots embedded deeply in the nation's flourishing healthcare sector. Known for its dedication to combining traditional Chinese medicinal practices with modern scientific research, the company stands out in an increasingly competitive market. Yipinhong's operations are centered around developing, manufacturing, and distributing a broad spectrum of medicinal products that adhere to the highest quality standards. By focusing on therapeutic areas such as respiratory, cardiovascular, and gastrointestinal health, they strategically align with the growing demand for reliable medicinal solutions. What makes Yipinhong truly distinctive is its investment in research and development that drives innovation. This focus not only ensures a continuous pipeline of new products but positions them as a leader in the integration of traditional remedies with cutting-edge pharmaceutical science. The company thrives on a business model that maximizes its robust distribution network, encompassing both domestic and international markets. Yipinhong capitalizes on its vast network of sales agents and partnerships with hospitals, clinics, and pharmacies to ensure its products reach consumers efficiently. This network amplifies their revenue streams by tapping into various segments within the pharmaceutical supply chain. Moreover, Yipinhong's strategic collaborations for research and development and their participation in healthcare industry events bolster their market presence and brand recognition. By maintaining a harmonious balance between traditional approaches and modern demands, Yipinhong not only captures a unique market position but also sets a benchmark in pharmaceutical excellence and innovation.

Intrinsic Value
9.15 CNY
Overvaluation 73%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-53.4%
=
Operating Income
¥-547.5m
/
Revenue
¥1B
What is Yipinhong Pharmaceutical Co Ltd's current Operating Margin?

The current Operating Margin for Yipinhong Pharmaceutical Co Ltd is -53.4%, which is below its 3-year median of -7.1%.

How has Operating Margin changed over time?

Over the last 3 years, Yipinhong Pharmaceutical Co Ltd’s Operating Margin has decreased from 11.4% to -53.4%. During this period, it reached a low of -53.4% on Oct 30, 2025 and a high of 15.2% on Mar 31, 2023.

Back to Top